NCT02351505View on ClinicalTrials.gov

Selinexor in Treating Patients With Relapsed Small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

March 31, 2016

Conditions
Recurrent Small Cell Lung Carcinoma
Interventions
DRUG

Selinexor

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Pharmacological Study

Correlative studies

Trial Locations (1)

43210

Ohio State University Comprehensive Cancer Center, Columbus

Sponsors

Lead Sponsor

Erin Bertino
All Listed Sponsors
collaborator

Karyopharm Therapeutics Inc

INDUSTRY

lead

Erin Bertino

OTHER